Astrana Health reported strong third-quarter results driven by the Astrana care model and value-based care enablement platform, demonstrating strong organic and inorganic growth while effectively managing costs and delivering high-quality care. The company is confident in its platform’s ability to improve access, quality, and coordination of care for around 1.1 million patients.
Strong third quarter reflects the outcomes of the Astrana care model and value-based care enablement platform.
Continued to see strong organic and inorganic growth across businesses.
Delivered high-quality care and managed costs effectively in the quarter.
Confident in the platform’s ability to continue improving access, quality, and coordination of care for around 1.1 million patients.
Astrana Health is raising its revenue guidance and narrowing its net income attributable to Astrana, Adjusted EBITDA, and EPS guidance for the year ending December 31, 2024, to incorporate CHS's financial contribution.
Analyze how earnings announcements historically affect stock price performance